Grant further strengthens Poolbeg’s global intellectual property (“IP”) portfolio
Poolbeg Pharma PLC (AIM:POLB) Termination of proposed combination with HOOKIPA
Termination of proposed combination with HOOKIPA Pharma Inc.
Poolbeg Pharma PLC (AIM:POLB) Offer Update – Extension to PUSU Deadline
Combination of Poolbeg and HOOKIPA Pharma Inc. Offer Update – Extension to PUSU Deadline
Poolbeg Pharma PLC (AIM:POLB) Update Potential Combination of Poolbeg & HOOKIPA
Further to the announcement on 2 January 2025 (the “2.4 Announcement”) and the update on the potential combination of Poolbeg and HOOKIPA announced on 7 January 2025, the following amendment
Poolbeg Pharma PLC (AIM:POLB) Update Potential Combination of Poolbeg & HOOKIPA
Further to the announcement on 2 January 2025 (the “2.4 Announcement”), the Boards of Poolbeg and HOOKIPA are pleased to confirm that significant HOOKIPA shareholder, Gilead Sciences Inc. (“Gilead”), has
Poolbeg Pharma PLC (AIM:POLB) Combination of Poolbeg and HOOKIPA Pharma Inc.
The boards of directors (each a “Board”) of HOOKIPA Pharma Inc. (“HOOKIPA”) and Poolbeg Pharma plc (“Poolbeg”) are pleased to announce that they have entered into non-binding discussions for an
European Green Transition Shows Strong Strategic Position in Critical Green Economy Assets
European Green Transition Plc (AIM: EGT), the green economy-focused investment company, is demonstrating robust progress across its diversified portfolio of strategic assets, positioning itself at the forefront of Europe’s critical
European Green Transition (AIM:EGT) Company Webinar Presentation
European Green Transition is positioning itself at a pivotal moment in the evolving landscape of the green economy. With a strategic shift from its original focus on mining to a
European Green Transition (AIM:EGT) Final results from the Olserum REE project
European Green Transition (AIM: EGT), a company developing green economy assets in Europe, is pleased to report positive results from the final five drill holes from its drill programme at
European Green Transition (AIM:EGT) Company Webinar Presentation
European Green Transition is positioning itself at a pivotal moment in the evolving landscape of the green economy. With a strategic shift from its original focus on mining to a
Poolbeg Pharma PLC (AIM:POLB) Presents POLB 001 data at 66th ASH Meeting
Poolbeg Pharma plc presents POLB 001 pre-clinical study data at the 66th American Society of Hematology (ASH) Annual Meeting
European Green Transition (AIM:EGT) Company Webinar Presentation 10th December 2024
About This Webinar